UB
CTKB icon

UMB Bank’s Cytek Biosciences CTKB Stock Holding History

UMB Bank’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.14K Buy
1,405
+23
+2% +$109 ﹤0.01% 1994
2025
Q4 		$6.98K Buy
1,382
+451
+48% +$2.09K ﹤0.01% 1937
2025
Q3 		$3.23K Buy
931
+67
+8% +$252 ﹤0.01% 1975
2025
Q2 		$2.94K Buy
864
+814
+1,628% +$2.71K ﹤0.01% 1946
2025
Q1 		$201 Sell
50
-323
-87% -$1.67K ﹤0.01% 2082
2024
Q4 		$2.42K Buy
373
+242
+185% +$1.44K ﹤0.01% 1898
2024
Q3 		$726 Buy
131
+81
+162% +$459 ﹤0.01% 2086
2024
Q2 		$279 Sell
50
-2
-4% -$12 ﹤0.01% 2108
2024
Q1 		$349 Buy
+52
New +$411 ﹤0.01% 2058

Other funds holding CTKB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UMB Bank's CTKB Position: Q1 2026 in Review

UMB Bank increased its Cytek Biosciences (CTKB) stake by 1.7% in Q1 2026, buying an estimated $109 and bringing the position to 1,405 shares worth $6.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

UMB Bank first reported a position in CTKB in Q1 2024 and has held it in 9 quarters since. The position peaked at $6.98K in Q4 2025. 165 funds tracked by Wall St. Rank hold CTKB as of Q1 2026.

  • UMB Bank held 1,405 shares of Cytek Biosciences worth $6.14K as of Q1 2026.
  • UMB Bank bought 23 Cytek Biosciences shares in Q1 2026, an estimated $109.
  • Cytek Biosciences made up ﹤0.01% of UMB Bank's portfolio in Q1 2026, its #1994 holding.
  • UMB Bank first reported a position in Cytek Biosciences in Q1 2024 and has held it in 9 quarters since.
  • UMB Bank's Cytek Biosciences position peaked at $6.98K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Cytek Biosciences as of Q1 2026.

Based on UMB Bank's 13F filing for Q1 2026, filed 11 May 2026.